Aurobindo Pharma Buyback Record Date is 17 April 2026.
Aurobindo Pharma is a vertically integrated pharmaceutical company engaged in the development, manufacturing, and commercialisation of a wide range of generic formulations and active pharmaceutical ingredients (APIs) for global markets. The company operates across key therapeutic segments, including anti-infectives, cardiovascular, central nervous system (CNS), gastroenterology, and antiretrovirals.
Aurobindo’s business model is built on strong backward integration, with significant in-house API manufacturing capabilities that support its formulations portfolio. This provides cost efficiencies, supply chain stability, and better control over product quality. The company has a strong presence in regulated markets such as the United States and Europe, where it supplies oral solids, injectables, and specialty products through its extensive manufacturing and regulatory infrastructure.
Over the years, Aurobindo has strategically expanded its portfolio from commoditised generics to more complex formulations, including injectables, biosimilars, and speciality pharmaceuticals. With 29+ manufacturing facilities approved by global regulatory authorities and a diversified geographic presence, Aurobindo Pharma remains a key player in the global generics industry, leveraging scale, integration, and product diversification to drive sustainable growth.
Aurobindo Pharma Buyback Record Date, Other Details
| Aurobindo Pharma Buyback Dates | Coming soon |
| Aurobindo Pharma Buyback Price | INR 1,475 per share |
| Market Price on Buyback Approval | 10.24% |
| Buyback Premium on Market Price | INR 1,330 |
| Buyback Offer Size (Shares) | 54,23,728 shares |
| Buyback Offer Size (Amount) | INR 800 crore |
| Offer Type | Tender |
| Promoter Participation | Yes |
| Face Value | INR 1 per share |
| Listing At | BSE, NSE |
Aurobindo Pharma Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 31 March 2026 |
| Buyback Approval Date | 6 April 2026 |
| Public Announcement of Buyback | Coming soon |
| Aurobindo Pharma Buyback Record Date | 17 April 2026 |
| Buyback Opening Date | Coming soon |
| Buyback Closing Date | Coming soon |
| Cut-off Date to receive completed tender forms by Registrar | Coming soon |
| Verification Date by the Registrar | Coming soon |
| Return of unaccepted shares by Registrar | Coming soon |
| Extinguishment of accepted shares | Coming soon |
Aurobindo Pharma Buyback 2026 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Aurobindo Pharma Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | – | 3.68* |
| General category (for all other Eligible Shareholders) | – | – |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Aurobindo Pharma Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Total Income | 24,855 | 29,002 | 31,724 |
| Total Expenses | 21,148 | 23,176 | 25,173 |
| Net Income | 1,928 | 3,169 | 3,484 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,475 |
| Maximum shares for small shareholders (2,00,000/1,475) | 136 shares * |
| The closing price of the stock as of 6 April 2026 | INR 1,338** |
| Maximum amount invested in buyback (INR 1,338×136 shares) | INR 1,81,968 |
** For simplicity, we have considered the price on the buyback approval date
Aurobindo Pharma Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 136 | 4 | 4 (100%) | 548 | 0.30 |
| 136 | 4 | 8 (200%) | 1,096 | 0.60 |
| 136 | 4 | 12 (300%) | 1,644 | 0.90 |
Registrar of Aurobindo Pharma Buyback 2026
Coming soon
Manager of Aurobindo Pharma Buyback 2026
Coming soon
The Process to Participate in Aurobindo Pharma Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Aurobindo Pharma buyback dates?
Aurobindo Pharma buyback opens on April 2026 and closes on April 2026.
Which type of buyback is Aurobindo Pharma’ buyback offer?
Aurobindo Pharma’ buyback is a tender offer.
What is Aurobindo Pharma buyback price?
Aurobindo Pharma’ buyback price is INR 1,475 per share.
What is the Aurobindo Pharma buyback record date?
Aurobindo Pharma buyback record date is 17 April 2026.
How to participate in Aurobindo Pharma share buyback?
Aurobindo Pharma’s share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
